James C. Lanter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
James C. Lanter has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Zhihua Sui
Johnson & Johnson Pharmaceutical Research and Development L.L.C., 665 Stockton Drive, Exton, PA 19341, USA
5 shared publicationsJames J. Fiordeliso
Johnson & Johnson Pharmaceutical Research and Development L.L.C., 665 Stockton Drive, Exton, PA 19341, USA
4 shared publicationsDo Won Hahn
Johnson & Johnson Pharmaceutical Research and Development L.L.C., 666 Stockton Drive, Exton, PA 19341, USA
2 shared publicationsGeorge F. Allan
Johnson & Johnson Pharmaceutical Research and Development L.L.C., 666 Stockton Drive, Exton, PA 19341, USA
2 shared publicationsMuh-Tsann Lai
Johnson & Johnson Pharmaceutical Research and Development L.L.C., 665 Stockton Drive, Exton, PA 19341, USA
2 shared publicationsOlivia Linton
Johnson & Johnson Pharmaceutical Research and Development L.L.C., 665 Stockton Drive, Exton, PA 19341, USA
2 shared publications
Latest Publications
- 1 May 2007
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (9) , 2545-2548
β-Alkylthio indolyl carbinols: Potent nonsteroidal antiandrogens with oral efficacy in a prostate cancer model
- 1 May 2007
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (9) , 2545-2548
β-Alkylthio indolyl carbinols: Potent nonsteroidal antiandrogens with oral efficacy in a prostate cancer model
- 1 January 2007
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (1) , 123-126
The discovery of a potent orally efficacious indole androgen receptor antagonist through in vivo screening
- 1 January 2007
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (1) , 123-126
The discovery of a potent orally efficacious indole androgen receptor antagonist through in vivo screening
- 1 November 2006
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (21) , 5646-5649
A bioisosteric approach to the discovery of indole carbinol androgen receptor ligands
- 1 November 2006
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (21) , 5646-5649
A bioisosteric approach to the discovery of indole carbinol androgen receptor ligands
- 19 November 2005
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 7 (26) , 5905-5907
Asymmetric Aza-Mannich Reactions of Sulfinimines: Scope and Application to the Total Synthesis of a Bromopyrrole Alkaloid
An asymmetric intermolecular aza variant of the Mannich reaction is reported utilizing chiral sulfinimine anions as the nucleophile and N-sulfonyl aldimines as the electrophilic component. A wide range of nucleophiles and electrophiles are tolerated by the reaction conditions, delivering the condensation products in good to excellent yield with a high degree of stereocontrol. Application of this methodology to the total synthesis of a natural product is reported.
- 19 November 2005
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 7 (26) , 5905-5907
Asymmetric Aza-Mannich Reactions of Sulfinimines: Scope and Application to the Total Synthesis of a Bromopyrrole Alkaloid
An asymmetric intermolecular aza variant of the Mannich reaction is reported utilizing chiral sulfinimine anions as the nucleophile and N-sulfonyl aldimines as the electrophilic component. A wide range of nucleophiles and electrophiles are tolerated by the reaction conditions, delivering the condensation products in good to excellent yield with a high degree of stereocontrol. Application of this methodology to the total synthesis of a natural product is reported.
- 31 December 2003
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (3) , 656-662
Structure−Activity Relationships of N-Acyl Pyrroloquinolone PDE-5 Inhibitors
The discovery of the potent and selective PDE-5 inhibitory activity of a pyrroloquinolone scaffold prompted us to explore the SAR of its acyl derivatives. During the course of these studies, three structural series were found with K(i) values for PDE-5 in the subnanomolar range. Systematic modification of one of these leads produced a compound with excellent selectivity for PDE-5 over other phosphodiesterases and oral bioavailability of 15% in male rats. This compound also displayed in vivo efficacy in an anesthetized canine model of erection when dosed intravenously.
- 31 December 2003
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (3) , 656-662
Structure−Activity Relationships of N-Acyl Pyrroloquinolone PDE-5 Inhibitors
The discovery of the potent and selective PDE-5 inhibitory activity of a pyrroloquinolone scaffold prompted us to explore the SAR of its acyl derivatives. During the course of these studies, three structural series were found with K(i) values for PDE-5 in the subnanomolar range. Systematic modification of one of these leads produced a compound with excellent selectivity for PDE-5 over other phosphodiesterases and oral bioavailability of 15% in male rats. This compound also displayed in vivo efficacy in an anesthetized canine model of erection when dosed intravenously.